NEWARK, N.J., Sept. 19, 2024 /PRNewswire/ — BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announces that it has appointed Syed T. Husain as its new Chief Executive Officer (CEO), and as a member of the Board of Directors. BioCentriq,…